Combined Use of Low-dose Sugammadex Plus Neostigmine Administered for Reversal of Rocuronium
Clinical trial NCT03328312 · UNKNOWN
Trial details
- NCT number
- NCT03328312
- Sponsor
- Iuliu Hatieganu University of Medicine and Pharmacy
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-01
- Primary completion
- 2018-03-01
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.